Delivery Order SPE2DB24D6044-SPE2DB24FLHDF

Award Date 9/23/24
Potential Completion Date 9/24/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $8,806.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ABRYSVO VIAL WITH DILUENTS. The order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to support military treatment programs and...
The Defense Logistics Agency (DLA) awarded a $4,518.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of ABRYSVO vials with diluent syringes. This contract, which has a completion date of November 13, 2024, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $10,482.55 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565931324 ABRYSVO VIAL WITH DILUENT SYRGS. This product is a medical supply used to support military treatment programs and facilities worldwide. The contract has a firm fixed price and an ultimate completion date of September 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ABRYSVO VIAL WITH DILUENT SYRGS. The contract has a ceiling value of $2,018.02 and a completion date of June 26, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $4,484.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a period of performance through June 13, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ABRYSVO vials with diluent syringes. The contract has a ceiling value of $11,679.50 and a period of performance through December 23, 2024. It is a firm-fixed-price contract, with no designated set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,248.75 firm fixed-price delivery order covers the supply of ABRYSVO vials with diluent syringes, with a performance period ending on November 12, 2024. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, with a ceiling value of $6,403.84 and a completion date of February 25, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, with a firm fixed price ceiling value of $1,440.44 and a performance period through May 29, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $3,505.20 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has a firm fixed price, is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, medical supplies used in healthcare settings. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which covers the delivery of...
  • SPE2DB24D6044
    Indefinite Delivery Contract
  • SPE2DB24D6044-SPE2DB24FLHDF
    Delivery Order

This is a $2,425.72 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ABRYSVO Vial with Diluent Syringes. The contract has an ultimate completion date of September 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/23/24, 2:37 PM